- NCT00000356
Evaluation of L-alpha-acetylmethadol (LAAM) in Methadone Patients - 5
Phase 2Completed - NCT00000232
Alternate Day Buprenorphine Administration, Phase IX - 14
Phase 2Completed - NCT00000231
Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13
Phase 2Completed - NCT00000230
Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12
Phase 2Completed - NCT00000229
Buprenorphine Detox With Two Types of Treatment. BBD II - 11
Phase 2Completed - NCT00000228
Buprenorphine Detox With Two Types of Treatment. BBD I - 10
Phase 2Completed - NCT00000357
Buprenorphine Maintenance for Opiate Dependence - 6
Phase 2Completed - NCT00000227
Alternate-Day Buprenorphine Administration. Phase VIII - 9
Phase 2Completed - NCT00000226
Alternate-Day Buprenorphine Administration. Phase VII - 8
Phase 2Completed - NCT00000225
Alternate-Day Buprenorphine Administration. Phase VI - 7
Phase 2Completed - NCT00000224
Alternate-Day Buprenorphine. Phase V - 6
Phase 1Completed - NCT00000223
Alternate-Day Buprenorphine Administration. Phase IV - 5
Phase 2Completed - NCT00000222
Alternate-Day Buprenorphine Administration. Phase II - 4
Phase 1Completed - NCT00000221
Alternate-Day Buprenorphine Administration. Phase I - 3
Phase 1Completed - NCT00000220
Gradual Vs. Rapid Buprenorphine Detoxification - 2
Phase 1Completed - NCT00000219
Buprenorphine Dose Alteration Study - 1
Phase 1Completed - NCT00000218
Pharmacotherapy and Intensive Treatment - 2
Phase 4Completed - NCT00000217
Pharmacotherapy and Intensive Treatment of Drug Abuse - 1
Phase 2Completed - NCT00000216
Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1
Phase 3Completed - NCT00000358
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7
Phase 1Completed - NCT00000215
IV Cocaine Abuse: A Laboratory Model - 4
Phase 2Completed - NCT00000214
IV Cocaine Abuse: A Laboratory Model - 3
Phase 2Completed - NCT00000213
IV Cocaine Abuse: A Laboratory Model - 2
Phase 2Completed - NCT00000212
IV Cocaine Abuse: A Laboratory Model - 1
Phase 2Completed - NCT00000211
Treatment Efficacy for Drug Abuse and AIDS Prevention - 2
Phase 2Completed - NCT00000210
Treatment Efficacy for Drug Abuse and AIDS Prevention - 1
Phase 2Completed - NCT00000209
Buprenorphine Dosing Interval - 5
Phase 2Completed - NCT00000208
Methadone/Buprenorphine Cross-Over Study - 4
Phase 2Completed - NCT00000207
Multicenter Clinical Trial of Buprenorphine - 3
Phase 3Completed - NCT00000206
Clinical Rescue Protocol - 2
Phase 2Completed - NCT00000205
Buprenorphine Maintenance Protocol - 1
Phase 3Completed - NCT00000204
Buprenorphine Maintenance for Opioid Addicts - 3
Phase 2Completed - NCT00000203
Buprenorphine Maintenance for Opioid Addicts - 2
Phase 2Completed - NCT00000202
Buprenorphine Maintenance for Opioid Addicts - 1
Phase 2Completed - NCT00000201
Pharmacological Modulation of Cocaine Effects - 1
Phase 2Completed - NCT00000200
Cocaine Effects in Humans: Physiology and Behavior - 1
Phase 2Completed - NCT00000199
Piracetam for Treatment of Cocaine Addiction, Phase II - 4
Phase 1Withdrawn - NCT00000198
Piracetam for Treatment of Cocaine Addiction - 3
Phase 1Completed - NCT00000197
Propranolol for Treatment of Cocaine Addiction - 2
Phase 2Completed - NCT00000196
Neurobiology of Opioid Dependence: 5 - 5
Phase 2Withdrawn - NCT00000195
Neurobiology of Opioid Dependence: 4 - 4
Phase 2Withdrawn - NCT00000194
Neurobiology of Opioid Dependence: 3 - 3
Phase 2Withdrawn - NCT00000193
Neurobiology of Opioid Dependence: 2 - 2
Phase 2Withdrawn - NCT00000192
Neurobiology of Opioid Dependence: 1 - 1
Phase 2Withdrawn - NCT00000191
Carbamazepine Treatment for Cocaine Dependence - 5
Phase 2Completed - NCT00000190
Cocaine in Parotid Saliva, Blood and Urine - 4
Phase 1Completed - NCT00000189
Gepirone vs Placebo in Treatment of Cocaine Dependence - 3
Phase 2Completed - NCT00000188
Selegiline in Treatment of Cocaine Dependence - 2
Phase 2Completed - NCT00000187
Ritanserin in Treatment of Cocaine Dependence - 1
Phase 2Completed - NCT00000259
Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11
Not ApplicableCompleted - NCT00000350
Effects of Stimulant Dependence on Human Striatal Dopamine System - 15
Phase 1Unknown - NCT00000318
Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1
Phase 2Completed - NCT00000316
Human Dopamine Transported Imaging in Cocaine Abuse: 2 - 2
Phase 1Completed - NCT00000315
Human Dopamine Transported Imaging in Cocaine Abuse: 1 - 1
Phase 1Completed - NCT00000314
M-CPP and Fenfluramine in Cocaine Addicts - 3
Phase 2Completed - NCT00000313
Predictive Values of Serotonergic Alterations for Outcome - 2
Phase 1Terminated - NCT00000312
Alterations in Serotonergic Functions in Cocaine Addicts - 1
Phase 1Completed - NCT00000311
Combining Behavioral Treatment With Agonist Maintenance - 1
Phase 3Completed - NCT00000310
Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2
Phase 2Terminated - NCT00000309
Serotonin/Dopamine Antagonism of Cocaine Effect: 1 - 1
Phase 2Terminated - NCT00000307
Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4
Phase 2Completed - NCT00000306
Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3
Phase 2Completed - NCT00000305
Amphetamine Cocaine Interaction Study - 2
Phase 1Terminated - NCT00000351
Cognitive Correlates of Substance Abuse, Part 2 - 16
Unknown - NCT00000303
Rapid Evaluation of Baclofen for Treatment of Cocaine Abuse/Dependence - 6
Phase 2Completed - NCT00000302
Study Comparing Liquid and Tablet Buprenorphine Formulations - 5
Phase 3Completed - NCT00000301
Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4
Phase 2Completed - NCT00000300
Feasibility Study of Take-Home LAAM Medication - 3
Phase 4Completed - NCT00000299
Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2
Phase 2Completed - NCT00000298
Buprenorphine Combination Tablet Feasibility - 1
Phase 2Completed - NCT00000297
Effects of Labetalol on Nicotine Administration in Humans - 14
Phase 2Completed - NCT00000296
Role of Metabolites in Nicotine Dependence (4) - 13
Phase 2Completed - NCT00000295
Progesterone Treatment in Female Smokers - 12
Phase 2Completed - NCT00000294
Effects of Carvedilol on Cocaine Use in Humans - 11
Phase 2Completed - NCT00000293
Effect of Nefazodone on Relapse in Females With Cocaine Abuse - 10
Phase 3Completed - NCT00000292
Acute Withdrawal From Smoked Cocaine - 9
Phase 1Completed - NCT00000352
Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients - 1
Phase 2Completed - NCT00000291
Effects of Labetalol on Human Cocaine Use - 8
Phase 2Completed - NCT00000290
Stress Hormones and Human Cocaine Use - 7
Phase 1Completed - NCT00000289
Role of Metabolites in Nicotine Dependence (3) - 6
Phase 2Completed - NCT00000288
Role of Metabolites in Nicotine Dependence (2) - 5
Phase 2Completed - NCT00000287
Relapse Patterns in Female Cocaine Users - 4
Completed - NCT00000286
Effects of Nefazodone on Treatment of Female Cocaine Abusers - 3
Phase 2Completed - NCT00000285
Effects of Phenytoin on Cocaine Use in Humans - 2
Phase 1Completed - NCT00000284
Role of Metabolites in Nicotine Dependence (1) - 1
Phase 2Completed - NCT00000353
Trial of Buprenorphine/Naloxone for Opiate Dependence - 2
Phase 2Completed - NCT00000282
Pemoline for Cocaine Abuse - 7
Phase 2Completed - NCT00000281
Pharmacotherapy for Schizophrenic Drug Users - 6
Phase 2Completed - NCT00000280
Glutaminergic Agents for Cocaine Abuse - 5
Phase 1Completed - NCT00000279
Novel Medications for Opiate Detoxification - 4
Phase 2Completed - NCT00000278
Disulfiram for Cocaine-Alcohol Abuse - 3
Phase 2Completed - NCT00000354
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3
Phase 1Completed - NCT00000277
Mazindol for Cocaine Abuse - 2
Phase 2Completed - NCT00000276
Dopamine Reuptake Inhibitors of Cocaine Abuse - 1
Phase 1Terminated - NCT00000275
Cocaine Abuse and ADHD - 10
Phase 2Completed - NCT00000320
Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1
Phase 1Completed - NCT00000319
Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2
Phase 2Completed - NCT00000347
Risperidone for Treatment of Cocaine Dependence in Outpatients - 12
Phase 2Completed - NCT00000345
Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10
Phase 1Completed - NCT00000344
Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9
Phase 2Completed